ITM0101
ITM0101
- Catalog: ITM0101
- Gene/Protein: ENG
- Product Description: Immunotag™ CD105 Monoclonal Antibody
504.0000
Price in reward points: 504
Your shopping cart is empty!
Antibody Specification | |
Datasheet | |
Target Protein | CD105 |
Clonality | Monoclonal |
Storage/Stability | -20°C/1 year |
Application | WB,IHC-p,IF,FCM,ELISA |
Recommended Dilution | Western Blot: 1/500 - 1/2000. Immunohistochemistry: 1/200 - 1/1000. Immunofluorescence: 1/200 - 1/1000. Flow cytometry: 1/200 - 1/400. ELISA: 1/10000. Not yet tested in other applications. |
Concentration | 1 mg/ml |
Reactive Species | Human |
Host Species | Mouse |
Immunogen | Purified recombinant fragment of human CD105 expressed in E. Coli. |
Specificity | CD105 Monoclonal Antibody detects endogenous levels of CD105 protein. |
Purification | Affinity purification |
Form | Ascitic fluid containing 0.03% sodium azide. |
Gene Name | ENG |
Accession No. | P17813 Q63961 |
Alternate Names | ENG; END; Endoglin; CD antigen CD105 |
Description | endoglin(ENG) Homo sapiens This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013], |
Protein Expression | Liver,Placenta,Thyroid,Umbilical vein, |
Subcellular Localization | extracellular space,nucleoplasm,cytoplasm,focal adhesion,external side of plasma membrane,cell surface,integral component of membrane,receptor complex,transforming growth factor beta receptor homodimeric complex,endothelial microparticle, |
Protein Function | disease:Defects in ENG are the cause of hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300, 108010]; also known as Osler-Rendu-Weber syndrome 1 (ORW1). HHT1 is an autosomal dominant multisystemic vascular dysplasia, characterized by recurrent epistaxis, muco-cutaneous telangiectases, gastro-intestinal hemorrhage, and pulmonary (PAVM), cerebral (CAVM) and hepatic arteriovenous malformations; all secondary manifestations of the underlying vascular dysplasia. Although the first symptom of HHT1 in children is generally nose bleed, there is an important clinical heterogeneity.,function:Major glycoprotein of vascular endothelium. May play a critical role in the binding of endothelial cells to integrins and/or other RGD receptors.,subunit:Homodimer that forms an heteromeric complex with the signaling receptors for transforming growth factor-beta: TGF-beta receptors I and/or II. It is able to bind TGF-beta 1, and 3 efficiently and TGF-beta 2 less efficiently. Interacts with TCTEX1D4.,tissue specificity:Endoglin is restricted to endothelial cells in all tissues except bone marrow., |
Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |